News Conference News CRT 2018 Ticagrelor: Better Platelet Blockade Post-TAVR? Michael O'Riordan March 07, 2018
News Daily News One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL Michael O'Riordan February 12, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk Yael L. Maxwell November 28, 2017
News Daily News No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib Michael O'Riordan September 29, 2017
News Conference News ESC 2017 EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib Todd Neale September 05, 2017
News Conference News EuroPCR 2017 EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure Michael O'Riordan May 24, 2017
News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Daily News Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows Michael O'Riordan March 31, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News Avoid Simvastatin, Lovastatin in Dabigatran-Treated Patients, Analysis Suggests Todd Neale November 24, 2016
News Conference News AHA 2016 Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients Michael O'Riordan November 16, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
News Daily News FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm Michael O'Riordan October 11, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care Michael O'Riordan June 29, 2016
News Daily News Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire Michael O'Riordan June 24, 2016